Epigallocatechin-3-gallate is an inhibitor of Na+,K+-ATPase by favoring the E1 conformation

Biochemical Pharmacology

Volumn 78, Issue 8, 2009, Pages 1069-1074

  Ochiai, Hideo ^a   Takeda, Kazuo ^a   Soeda, Shiori ^a   Tahara, Yoshikazu ^b   Takenaka, Hitoshi ^b   Abe, Kazuhiro ^c   Hayashi, Yutaro ^b   Noguchi, Shunsuke ^a   Inoue, Masumi ^a   Schwarz, Silvia ^d   Schwarz, Wolfgang ^d,e   Kawamura, Masaru ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d Shanghai Research Center of Acupuncture and Meridian   (China)

^e MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

Author keywords

Epigallocatechin 3 gallate; Inhibition; Na+,K+ ATPase; P type ATPase; Phospholipid

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CATECHIN; EPICATECHIN; EPICATECHIN 3 GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; HYDROGEN POTASSIUM ADENOSINE TRIPHOSPHATASE; MYOSIN ADENOSINE TRIPHOSPHATASE; PHOSPHOLIPID; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG; VANADIC ACID;

ARTICLE; CHEMICAL INTERACTION; CONTROLLED STUDY; ENZYME CONFORMATION; ENZYME INHIBITION; IC 50; PRIORITY JOURNAL;

ANIMALS; CATECHIN; INHIBITORY CONCENTRATION 50; KIDNEY; MOLECULAR CONFORMATION; SODIUM-POTASSIUM-EXCHANGING ATPASE; SWINE;

EID: 69349089920     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.06.007     Document Type: Article

References (27)

1. Schoner W., and Scheiner-Bobis G. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth. Am J Physiol Cell Physiol 293 (2007) C509-C536
2. Li J., Zelenin S., Aperia A., and Aizman O. Low doses of ouabain protect from serum deprivation-triggered apoptosis and stimulate kidney cell proliferation via activation of NF-kappaB. J Am Soc Nephrol 17 (2006) 1848-1857
3. Bettuzzi S., Brausi M., Rizzi F., Castagnetti G., Peracchia G., and Corti A. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66 (2006) 1234-1240
4. Rizvi S.I., and Zaid M.A. Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins. Clin Chim Acta 354 (2005) 59-67
5. +-ATPase is the αβ-protomer. Determination by low-angle laser light scattering photometry coupled with high-performance gel chromatography for substantially simultaneous measurement of ATPase activity and molecular weight. Biochim Biophys Acta 983 (1989) 217-229
6. +-ATPase solubilized in the presence of short-chain fatty acids. Biochemistry 47 (2008) 6039-6051
7. Yen L.A., Cosgrove P., and Holt W. SDS purification of porcine H,K-ATPase from gastric mucosa. Membr Biochem 9 (1990) 129-140
8. Takenaka H., Adler P.N., and Katz A.M. Calcium fluxes across the membrane of sarcoplasmic reticulum vesicles. J Biol Chem 257 (1982) 12649-12656
9. Lanzetta P.A., Alvarez L.J., Reinach P.S., and Candia O.A. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem 100 (1979) 95-97
10. +-ATPase for control of cation interaction and conformational changes. J Biol Chem 277 (2002) 38607-38617
11. Klodos I., Post R.L., and Forbush B. Kinetic heterogeneity of phosphoenzyme of Na,K-ATPase modeled by unmixed lipid phases. Competence of the phosphointermediate. J Biol Chem 269 (1994) 1734-1743
12. Sarkadi B., Enyedi A., Foldes-Papp Z., and Gardos G. Molecular characterization of the in situ red cell membrane calcium pump by limited proteolysis. J Biol Chem 261 (1986) 9552-9557
13. +-ATPase plays a pivotal role in the ion translocating conformational changes. Biochemistry 36 (1997) 13312-13324
14. Kamihara M., Nakazawa H., Kira A., Mizutani Y., Nakamura M., and Nakayama T. Interaction of tea catechins with lipid bilayers investigated by a quartz-crystal microbalance analysis. Biosci Biotechnol Biochem 72 (2008) 1372-1375
15. Murakami S., Muramatsu M., and Otomo S. Gastric H+,K(+)-ATPase inhibition by catechins. J Pharm Pharmacol 44 (1992) 926-928
16. Doss M.X., Potta S.P., Hescheler J., and Sachinidis A. Trapping of growth factors by catechins: a possible therapeutical target for prevention of proliferative diseases. J Nutr Biochem 16 (2005) 259-266
17. Khan N., Afaq F., Saleem M., Ahmad N., and Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 66 (2006) 2500-2505
18. Chow H.H., Hakim I.A., Vining D.R., Crowell J.A., Ranger-Moore J., Chew W.M., et al. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11 (2005) 4627-4633
19. Beak W.K., Jang B.C., Lim J.H., Kwon T.K., Lee H.Y., Cho C.H., et al. Inhibitory modulation of ATP-sensitive potassium channels by gallate-ester moiety of (-)-epigallocatechin-3-gallate. Biochem Pharmacol 70 (2005) 1560-1567
20. Lee W.J., Shim J.-Y., and Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 68 (2005) 1018-1030
21. Leone M., Zhai D., Sareth S., Kitada S., Reed J.C., and Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res 63 (2003) 8118-8121
22. Jin J.-Y., Park S.-H., Bae J.-H., Cho H.-C., Lim J.-G., Park W.S., et al. Uncoupling by (-)-epigallocatechin-3-gallate of ATP-sensitive potassium channels from phosphatidylinositol polyphosphates and ATP. Pharmacol Res 56 (2007) 237-247
23. Schoner W. Endogenous cardiac glycosides, a new class of steroid hormones. Eur J Biochem 269 (2002) 2440-2448
24. Aizman O., Uhlen P., Lai M., Brismar H., and Aperia A. Ouabain, a steroid hormone that signals with slow calcium oscillations. Proc Natl Acad Sci USA 98 (2001) 13420-13424
25. Albers R.W. Biochemical aspects of active transport. Annu Rev Biochem 36 (1967) 727-756
26. Cantley Jr. L.C., Cantley L.G., and Josephson L. A characterization of vanadate interactions with the (Na,K)-ATPase. Mechanistic and regulatory implications. J Biol Chem 253 (1978) 7361-7368
27. Hegyvary C., Chigurupati R., Kang K., and Mahoney D. Reversible alterations in the kinetics of cardiac sodium- and potassium-activated adenosine triphosphatase after partial removal of membrane lipids. J Biol Chem 255 (1980) 3068-3074